Items where contributor is "Lohri, Andreas N."

Group by: Date | Item Type | Refereed | No Grouping

Hitz, Felicitas and Ketterer, Nicolas and Lohri, Andreas and Mey, Ulrich and Pederiva, Stefanie and Renner, Christoph and Taverna, Christian and Hartmann, Anna and Yeow, Karen and Bodis, Stephan and Zucca, Emanuele. (2011) Diagnosis and treatment of follicular lymphoma. Swiss Medical Weekly, Vol. 141 , w13247.

Toniolo, Martin and Ceschi, Alessandro and Meli, Marianne and Lohri, Andreas and Favre, Geneviève. (2011) Haemolytic anaemia and abdominal pain : a cause not to be missed. British journal of clinical pharmacology, Vol. 72, no. 1. pp. 168-169.

Hess, V. and Pratsch, S. and Potthast, S. and Lee, L. and Winterhalder, R. and Widmer, L. and Cescato, C. and Lohri, A. and Jost, L. and Stillhart, P. and Pestalozzi, B. and Herrmann, R.. (2010) Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC) : a phase I/II trial. Annals of oncology, Vol. 21, H. 12. pp. 2390-2395.

Engert, Andreas and Josting, Andreas and Haverkamp, Heinz and Villalobos, Matthias and Lohri, Andreas and Sökler, Martin and Zijlstra, Josée and Sturm, Isrid and Topp, Max S. and Rank, Andreas and Zenz, Thorsten and Vogelhuber, Martin and Nogova, Lucia and Borchmann, Peter and Fuchs, Michael and Flechtner, Hans-Henning and Diehl, Volker. (2010) Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma : results of the randomized placebo-controlled GHSG HD15EPO trial. Journal of clinical oncology, Vol. 28, H. 13. pp. 2239-2245.

Ruhstaller, Thomas and Templeton, Arnoud and Ribi, Karin and Schuller, Jan C. and Borner, Markus and Thierstein, Sandra and von Moos, Roger and Pederiva, Stefanie and Lohri, Andreas and Lombriser, Norbert and von Briel, Christian and Koeberle, Dieter and Popescu, Razvan. (2010) Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure : a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02). Onkologie, 33 (5). pp. 222-228.

Engert, Andreas and Plütschow, Annette and Eich, Hans Theodor and Lohri, Andreas and Dörken, Bernd and Borchmann, Peter and Berger, Bernhard and Greil, Richard and Willborn, Kay C. and Wilhelm, Martin and Debus, Jürgen and Eble, Michael J. and Sökler, Martin and Ho, Antony and Rank, Andreas and Ganser, Arnold and Trümper, Lorenz and Bokemeyer, Carsten and Kirchner, Hartmut and Schubert, Jörg and Král, Zdenek and Fuchs, Michael and Müller-Hermelink, Hans-Konrad and Müller, Rolf-Peter and Diehl, Volker. (2010) Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. The New England journal of medicine, Vol. 363, H. 7. pp. 640-652.

Martinelli, Giovanni and Schmitz, Shu-Fang Hsu and Utiger, Urs and Cerny, Thomas and Hess, Urs and Bassi, Simona and Okkinga, Emmie and Stupp, Roger and Stahel, Rolf and Heizmann, Marc and Vorobiof, Daniel and Lohri, Andreas and Dietrich, Pierre-Yves and Zucca, Emanuele and Ghielmini, Michele. (2010) Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98. Journal of clinical oncology, Vol. 28, H. 29. pp. 4480-4484.

Forrer, Flavio and Chen, Jianhua and Fani, Melpomeni and Powell, Pia and Lohri, Andreas and Müller-Brand, Jan and Moldenhauer, Gerhard and Maecke, Helmut R.. (2009) In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study. European journal of nuclear medicine and molecular imaging, Vol. 36. pp. 1443-1452.

Engert, Andreas and Diehl, Volker and Franklin, Jeremy and Lohri, Andreas and Dörken, Bernd and Ludwig, Wolf-Dieter and Koch, Peter and Hänel, Mathias and Pfreundschuh, Michael and Wilhelm, Martin and Trümper, Lorenz and Aulitzky, Walter-Erich and Bentz, Martin and Rummel, Mathias and Sezer, Orhan and Müller-Hermelink, Hans-Konrad and Hasenclever, Dirk and Löffler, Markus. (2009) Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma : 10 years of follow-up of the GHSG HD9 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27. pp. 4548-4554.

Buser, A. and Stern, M. and Arber, C. and Medinger, M. and Halter, J. and Rovo, A. and Favre, G. and Lohri, A. and Tichelli, A. and Gratwohl, A.. (2008) Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Bone Marrow Transplantation, 42 (7). pp. 483-487.

Kobe, Carsten and Dietlein, Markus and Franklin, Jeremy and Markova, Jana and Lohri, Andreas and Amthauer, Holger and Klutmann, Susanne and Knapp, Wolfram H. and Zijlstra, Josee M. and Bockisch, Andreas and Weckesser, Matthias and Lorenz, Reinhard and Schreckenberger, Matthias and Bares, Roland and Eich, Hans Theodor and Mueller, Rolf-Peter and Fuchs, Michael and Borchmann, Peter and Schicha, Harald and Diehl, Volker and Engert, Andreas. (2008) Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood, 112 (10). pp. 3989-3994.